JP2015536326A - 羊膜由来接着細胞を利用する疼痛の治療 - Google Patents

羊膜由来接着細胞を利用する疼痛の治療 Download PDF

Info

Publication number
JP2015536326A
JP2015536326A JP2015538056A JP2015538056A JP2015536326A JP 2015536326 A JP2015536326 A JP 2015536326A JP 2015538056 A JP2015538056 A JP 2015538056A JP 2015538056 A JP2015538056 A JP 2015538056A JP 2015536326 A JP2015536326 A JP 2015536326A
Authority
JP
Japan
Prior art keywords
amdac
pain
mir
cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015538056A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536326A5 (enExample
Inventor
ヘルズベルグ ウリ
ヘルズベルグ ウリ
ジェイ． ハリリ ロバート
ジェイ． ハリリ ロバート
ピー．グルネイ ジョディ
ピー．グルネイ ジョディ
Original Assignee
アントフロゲネシス コーポレーション
アントフロゲネシス コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アントフロゲネシス コーポレーション, アントフロゲネシス コーポレーション filed Critical アントフロゲネシス コーポレーション
Publication of JP2015536326A publication Critical patent/JP2015536326A/ja
Publication of JP2015536326A5 publication Critical patent/JP2015536326A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2015538056A 2012-10-19 2013-10-18 羊膜由来接着細胞を利用する疼痛の治療 Pending JP2015536326A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261716091P 2012-10-19 2012-10-19
US61/716,091 2012-10-19
US201361783752P 2013-03-14 2013-03-14
US61/783,752 2013-03-14
PCT/US2013/065653 WO2014063035A2 (en) 2012-10-19 2013-10-18 Treatment of pain using amnion derived adherent cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018132024A Division JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療

Publications (2)

Publication Number Publication Date
JP2015536326A true JP2015536326A (ja) 2015-12-21
JP2015536326A5 JP2015536326A5 (enExample) 2016-12-08

Family

ID=50488901

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015538056A Pending JP2015536326A (ja) 2012-10-19 2013-10-18 羊膜由来接着細胞を利用する疼痛の治療
JP2018132024A Pending JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療
JP2020104367A Withdrawn JP2020180128A (ja) 2012-10-19 2020-06-17 羊膜由来接着細胞を利用する疼痛の治療
JP2022091267A Active JP7315755B2 (ja) 2012-10-19 2022-06-06 羊膜由来接着細胞を利用する疼痛の治療

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018132024A Pending JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療
JP2020104367A Withdrawn JP2020180128A (ja) 2012-10-19 2020-06-17 羊膜由来接着細胞を利用する疼痛の治療
JP2022091267A Active JP7315755B2 (ja) 2012-10-19 2022-06-06 羊膜由来接着細胞を利用する疼痛の治療

Country Status (6)

Country Link
US (1) US20160166618A1 (enExample)
EP (1) EP2909314B1 (enExample)
JP (4) JP2015536326A (enExample)
CA (1) CA2888772A1 (enExample)
DK (1) DK2909314T3 (enExample)
WO (1) WO2014063035A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016006270A (es) 2013-11-15 2016-09-07 Anthrogenesis Corp Composiciones que comprenden células perfundidas de placenta humana, subpoblaciones de las mismas y sus usos.
CN113679741B (zh) * 2021-09-13 2023-09-19 北京大学第一医院 人羊膜上皮干细胞在制备治疗顺铂诱导的急性肾损伤的药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012509087A (ja) * 2008-11-19 2012-04-19 アンスロジェネシス コーポレーション 羊膜由来接着細胞
WO2012083021A1 (en) * 2010-12-17 2012-06-21 Anthrogenesis Corporation Treatment of immune-related diseases and disorders using amnion derived adherent cells
US20120171180A1 (en) * 2010-12-30 2012-07-05 Sascha Abramson Compositions comprising amnion derived adherent cells and platelet-rich plasma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1210379B1 (en) 1999-04-16 2007-03-21 Wm. MARSH RICE UNIVERSITY Biodegradable poly(propylene fumarate) networks cross linked with poly(propylene fumarate)-diacrylate macromers
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
ES2420354T3 (es) * 2000-07-07 2013-08-23 Spectrum Pharmaceuticals, Inc. Métodos para el tratamiento de neuropatía periférica inducida por una enfermedad y afecciones relacionadas
NZ527849A (en) 2001-02-14 2006-09-29 Anthrogenesis Corp Post-partum mammalian placenta, its use and placental stem cells therefrom
DK2471904T3 (en) 2005-12-29 2019-02-18 Celularity Inc Placenta stem cell populations
US20090214484A1 (en) * 2008-02-22 2009-08-27 Nikolay Mironov Stem cell therapy for the treatment of central nervous system disorders
AU2010322808B9 (en) * 2009-11-30 2014-08-07 Pluri Biotech Ltd Adherent cells from placenta and use of same in disease treatment
KR20140022776A (ko) * 2010-11-16 2014-02-25 지우세페 마리네오 아편제 및 통상적인 전기 진통에 내성이 있는 신경병증 통증, 종양 통증 및 소아 통증을 신속히 억제하기 위한 장치 및 방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012509087A (ja) * 2008-11-19 2012-04-19 アンスロジェネシス コーポレーション 羊膜由来接着細胞
WO2012083021A1 (en) * 2010-12-17 2012-06-21 Anthrogenesis Corporation Treatment of immune-related diseases and disorders using amnion derived adherent cells
US20120171180A1 (en) * 2010-12-30 2012-07-05 Sascha Abramson Compositions comprising amnion derived adherent cells and platelet-rich plasma

Also Published As

Publication number Publication date
JP2020180128A (ja) 2020-11-05
JP7315755B2 (ja) 2023-07-26
WO2014063035A2 (en) 2014-04-24
CA2888772A1 (en) 2015-04-24
WO2014063035A3 (en) 2014-06-19
EP2909314A4 (en) 2016-10-12
HK1214299A1 (en) 2016-07-22
EP2909314A2 (en) 2015-08-26
DK2909314T3 (da) 2021-03-08
EP2909314B1 (en) 2020-12-02
US20160166618A1 (en) 2016-06-16
JP2022130406A (ja) 2022-09-06
JP2018188456A (ja) 2018-11-29

Similar Documents

Publication Publication Date Title
US11090339B2 (en) Treatment of pain using placental stem cells
US20120171180A1 (en) Compositions comprising amnion derived adherent cells and platelet-rich plasma
JP2016192966A (ja) 胎盤幹細胞を用いる血管形成
JP7315755B2 (ja) 羊膜由来接着細胞を利用する疼痛の治療
JP2022184911A (ja) 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療
US20220072063A1 (en) Treatment of diabetic peripheral neuropathy using placental cells
HK1214299B (en) Treatment of pain using amnion derived adherent cells
HK40005664A (en) Treatment of pain using placental stem cells
HK1192729A (en) Treatment of pain using placental stem cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161018

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161018

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170613

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170815

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180313